Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in demand for the company’s blockbuster psoriasis treatment.
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...
People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...
Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy ...
Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...
You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...
Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.
The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.
Let’s cover five psoriasis treatments that all Black individuals with psoriasis should avoid, based on the research.
Secukinumab delivers sustained efficacy and quality of life improvements in pediatric generalized pustular psoriasis (GPP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback